|
Panacea has supported IND and IDE studies in a multitude of therapeutic
arenas including the following:
| Therapeutic
Area |
Biologic |
Device |
Drug |
Diagnostic |
| Asthma/Allergy |
 |
|
 |
|
| Cardiovascular |
|
 |
 |
|
| Dermatology |
 |
 |
|
|
| Endocrinology |
|
|
 |
|
| Gastroenterology |
|
 |
 |
|
| Hematology |
 |
|
|
 |
| HIV/AIDS |
 |
|
 |
|
| Infectious Disease |
|
 |
 |
|
| Immunology |
 |
|
|
|
| Metabolism |
 |
|
|
|
| Nephrology |
|
 |
 |
|
| Neurology |
 |
|
 |
|
| Nuclear Medicine |
|
|
|
 |
| OB/GYN |
|
 |
|
|
| Oncology |
 |
|
 |
 |
| Ophthalmology |
 |
 |
 |
|
| Orthopedics |
|
 |
 |
|
| Psychiatry |
|
|
 |
|
| Pulmonology |
 |
 |
|
 |
| Radiology |
|
|
|
 |
| Surgery |
|
 |
|
|
| Urology |
|
 |
 |
|
| Vaccine |
 |
|
 |
|
Panacea is highly experienced in the following trial types:
- Phase I-IV
- Pivotal
- Post-Marketing
- Compassionate Use
- Registry
|